Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
36.04
+0.28 (0.78%)
Jan 14, 2026, 4:00 PM EST - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $2.08 billion as of January 15, 2026. Its market cap has increased by 6.42% in one year.
Market Cap
2.08B
Enterprise Value
1.57B
1-Year Change
6.42%
Ranking
Category
Stock Price
$36.04
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.08B, an increase of 350.24%. That is a compound annual growth rate of 32.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 2.08B | -3.69% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |